Author Archives: Scalper1

Myriad Genetics Hits High On Turnaround Plan

Genetic testing company Myriad Genetics (MYGN) hit a 52-week high on the stock market and got a couple of price-target increases Tuesday in the wake of its analyst day Monday. Myriad laid out a five-year plan to turn around its string of profit declines over the last five quarters. The business has been hit by two factors: the waning of publicity surrounding Angelina Jolie’s use of Myriad’s BRACAnalysis breast-cancer-gene test in 2013, and the

Apple Watch satisfaction badly lags first iPhone

A little over half of Apple Watch owners say they’re “very satisfied” with the device, well below the satisfaction levels for Apple’s (AAPL) original iPhone. In its first survey of Apple Watch owners, 451 Research found that 54% are “very satisfied” with Apple’s first smartwatch, while 33% are “somewhat satisfied,” 6% “somewhat unsatisfied” and 6% “very unsatisfied.” In 2007, ChangeWave Research, now owed by 451, surveyed users of the first iPhone